Coronary revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: 2-year follow-up from a large multicenter registry.

Introduction: Multivessel coronary artery disease (MVD) occurs in one‑third of patients with ST‑segment elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (pPCI). However, long‑term prognosis and readmission rates in this high‑risk group remain unclear.

Objectives: We aimed to evaluate the long‑term risk of cardiovascular events and readmissions in STEMI patients with MVD.